ARTICLE SUMMARY:
Having led Sofamor Danek (later Medtronic Sofamor Danek) to unprecedented heights in the dynamic spine market of the late 1990s and early 2000s, Michael DeMane eventually landed at Nevro, which revitalized a sleepy spinal cord stimulation industry with a novel technology and the clinical data to back it. Its improvements in the area of pain management led to one of the most successful recent IPOs in medtech.
For much of the period between 1995 to 2005, give or take a year or so on either end, the spine market behaved very much like many medical device segments of that time: an initial burst of technology created or enabled new procedures, which in turn spurred more growth and more innovation as surgeons and engineers easily found investors willing to back the new technology they developed.
